While tumor suppressive functions for FTO have been described in for example colorectal cancer and hepatocellular carcinoma, reports describing oncogenic functions in different cancer types including lung cancer, glioma and AML are far more abundant (reviewed in [20]). This evidence concerns the gene FTO and colorectal cancer.